Candriam S.C.A. Lexicon Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 02, 2019	SELL	$4.36 - $7.94 $2.22 Million - $4.04 Million	-509,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$10.32 - $13.06 $1.41 Million - $1.79 Million	137,000 Added 36.83%	509,000 $5.43 Million
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $811,200 - $1.42 Million	104,000 Added 38.81%	372,000 $4.46 Million
Q4 2017 Feb 07, 2018	SELL	$8.77 - $12.28 $219,250 - $307,000	-25,000 Reduced 8.53%	268,000 $2.65 Million
Q3 2017 Nov 03, 2017	BUY	$12.17 - $16.3 $3.57 Million - $4.78 Million	293,000	293,000 $3.6 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $200M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.